A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Sign up to get notified once we do.
Your doctor may prescribe Azulfidine EN to treat a variety of different autoimmune conditions. It is commonly prescribed for rheumatoid arthritis (RA), ulcerative colitis (UC), ankylosing spondylitis (off-label), Crohn’s disease (off-label), and psoriatic arthritis.
Azulfidine works by suppressing overacting cells of the immune system that are causing inflammation.
Azulfidine can be taken with or without food. The tablets have an enteric coating, so they cannot be chewed, crushed, or split. They should be swallowed whole. The enteric coating ensures that the active ingredient is not broken down by stomach acid and reaches the area where it is needed in the intestines.
The active ingredient in Azulfidine EN is sulfasalazine.
Common drug-drug interactions may include:
Tell your doctor if you have a history of liver or kidney problems, G6PD deficiency, or asthma.
Do not use Asulfizine EN if you have a sulfa allergy.
Ask your doctor and pharmacist about all warnings that apply to you.
Azulfidine side effects may include the following:
Buy Azulfidine EN online from Canada Pharmacy with a valid prescription.
Azulfidine EN [package insert]. New York, NY: Pfizer; 2012.